Clear cell sarcoma of soft tissue: A clinicopathologic, immunohistochemical, and molecular analysis of 33 cases

American Journal of Surgical Pathology

Volumn 32, Issue 3, 2008, Pages 452-460

  Hisaoka, Masanori ^a   Ishida, Tsuyoshi ^b,c   Kuo, Tseng Tong ^e   Matsuyama, Atsuji ^a   Imamura, Tetsuo ^d   Nishida, Kazunori ^f   Kuroda, Hiroshi ^f   Inayama, Yoshiaki ^g   Oshiro, Hisashi ^g   Kobayashi, Hiroshi ^h   Nakajima, Takashi ⁱ   Fukuda, Toshio ^j   Ae, Keisuke ^c   Hashimoto, Hiroshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b 1 7 1 Kohnodai   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f SAITAMA CANCER CENTER   (Japan)

^g YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^h SEIREI HAMAMATSU GENERAL HOSPITAL   (Japan)

ⁱ GUNMA UNIVERSITY   (Japan)

^j GUNMA UNIVERSITY   (Japan)

more..

Author keywords

Clear cell sarcoma; Fusion gene; Immunohistochemistry; RT PCR

Indexed keywords

HY ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SIZE; CLEAR CELL SARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIOID CELL; FEMALE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITOSIS RATE; MOLECULAR BIOLOGY; SEMINOMA; SOFT TISSUE SARCOMA; SPINDLE CELL; STATISTICAL ANALYSIS; TUMOR NECROSIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD34; ANTIGENS, CD57; ANTIGENS, NEOPLASM; CA-15-3 ANTIGEN; CALMODULIN-BINDING PROTEINS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; GENE FUSION; GENES, BCL-2; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, ERBB-2; RNA-BINDING PROTEINS; S100 PROTEINS; SARCOMA, CLEAR CELL; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; SYNAPTOPHYSIN; TRANSLOCATION, GENETIC;

EID: 40849150707     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31814b18fb     Document Type: Article

References (33)

1. Antonescu CR, Dal Cin P, Nafa K, et al. EWS-CREB1 is the predominant gene fusion in so-called angiomatoid fibrous histiocytoma (AFH) [Abstract]. Mod Pathol. 2007;20:12A.
2. Antonescu CR, Nafa K, Segal NH, et al. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma-association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res. 2006;12:5356-5362.
3. Antonescu CR, Tschernyavsky SJ, Woodruff JM, et al. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITFM transcripts and histopathological and ultrastructural analysis of 12 cases. J Mol Diagn. 2002;4:44-52.
4. Barr FG, Zhang PJ. The impact of genetics on sarcoma diagnosis: an evolving science. Clin Cancer Res. 2006;12:5256-5257.
5. Brown AD, Lopez-Terrada D, Denny CT, et al. Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene. Oncogene. 1995;10:1749-1756.
6. Chung EB, Enzinger FM. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol. 1983;7:405-413.
7. Coindre J-M, Hostein I, Terrier P, et al. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues. Clinicopathologic and molecular analysis of 44 patients from the French sarcoma group. Cancer. 2006;107:1055-1064.
8. d'Amore ESG, Ninfo V. Clear cell tumors of the somatic soft tissues. Semin Diagn Pathol. 1997;14:270-280.
9. Davis IJ, Kim JJ, Ozsolak F, et al. Oncogenic MITF dysregulation in clear cell sarcoma. Defining the MiT family of human cancers. Cancer Cell. 2006;9:473-484.
10. De Cesare D, Sassone-Corsi P. Transcription regulation by cyclic AMP-responsive factors. Prog Nucleic Acid Res Mol Biol. 2000;64:343-369.
11. Dim DC, Cooley LD, Miranda RN. Clear cell sarcoma of tendons and aponeuroses. A review. Arch Pathol Lab Med. 2007;131:152-156.
12. Enzinger FM. Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer. 1965;18:1163-1174.
13. Ferrari A, Casanova M, Bisogno G, et al. Clear cell sarcoma of tendons and aponeuroses in pediatric patients. A report from the Italian and German soft tissue sarcoma cooperative group. Cancer. 2002;94:3269-3276.
14. Folpe AL, Mentzel T, Lehr H-A, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin. A clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29:1558-1575.
15. Fujimura Y, Ohno T, Siddique H, et al. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene. 1996;12:159-167.
16. Garcia JJ, Kramer MJ, Mackey ZB, et al. Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma. Arch Path Lab Med. 2006;130:343-348.
17. Graadt van Roggen JF, Mooi WJ, Hogendoorn PCW. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol. 1998;186:3-7.
18. Haller KH, Mertens F, Jin Y, et al. Fusion of the EWSR1 and ATF1 genes without expression of the MITF-M transcript in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2005;44:97-102.
19. Hornick JL, Fletcher CDM. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol. 2002;117:188-193.
20. Kawai A, Hosono A, Nakayama R, et al. Clear cell sarcoma of tendons and aponeuroses. A study of 75 patients. Cancer. 2007;109:109-116.
21. Langezaal SM, Graadt van Roggen JF, Cleton-Jansen AM, et al. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer. 2001;84:535-538.
22. Li KK, Lee KA. MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription. Oncogene. 1998;16:1325-1331.
23. Lucas DR, Nascimento AG, Sim FH. Clear cell sarcoma of soft tissues. Mayo clinic experience with 35 cases. Am J Surg Pathol. 1992;16:1197-1204.
24. McGill GG, Horstmann M, Widlung HR, et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell. 2002;109:707-718.
25. Meis-Kindblom JM. Clear cell sarcoma of tendons and aponeuroses: a historical perspective and tribute to the man behind the entity. Adv Anat Pathol. 2006;13:286-292.
26. Montgomery EA, Meis JM, Ramos AG, et al. Clear cell sarcoma of tendons and aponeuroses. A clinicopathologic study of 58 cases with analysis of prognostic factors. Int J Surg Pathol. 1993;1:89-100.
27. Panagopoulos I, Mertens F, Debiec-Rychter M, et al. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer. 2002;99:560-567.
28. Patel RM, Downs-Kelly E,Weiss SW, et al. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol. 2005;18:1585-1590.
29. Sara AS, Evans HL, Benjamin RS. Malignant melanoma of soft parts (clear cell sarcoma). A study of 17 cases, with emphasis on prognostic factors. Cancer. 1990;65:367-374.
30. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998;11:728-734.
31. Suster S, Fisher C, Moran CA. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. Am J Surg Pathol. 1998;22:863-872.
32. Tsuji S, Hisaoka M, Morimitsu Y, et al. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription polymerase chain reaction using archival paraffin-embedded tissues. Am J Pathol. 1998;153:1807-1812.
33. Zucman J, Delattre O, Desmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genet. 1993;4:341-345.